| Title: | MR-PheWAS for the causal effects of serum magnesium on multiple disease outcomes in Caucasian descent |
| Journal: | iScience |
| Published: | 30 Sep 2021 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/34703991/ |
| DOI: | https://doi.org/10.1016/j.isci.2021.103191 |
| URL: | http://www.cell.com/article/S2589004221011597/pdf |
| Citations: | 4 (1 in last 2 years) as of 8 Aug 2024 |
Publication 5420
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Magnesium is integral to many physiological processes, whereas variations in its levels, even within the normal range, can have critical implications for health. To explore the broad clinical effects of varying serum magnesium levels, we performed a two-sample Mendelian randomization and phenome-wide association study (MR-PheWAS) in the UK Biobank cohort. In total, MR-PheWAS analysis implicated a causal role of serum magnesium levels in five disease groups and six disease outcomes. In addition, our study indicated the gender-specific effects of nine disease groups/outcomes in MR estimated effects. The protein-protein interaction network demonstrated an interaction between the serum magnesium-associated gene DCDC1 and the cataract- associated gene PAX6. The present study verified several previously reported disease outcomes and identified novel potential disease outcomes for serum magnesium levels. The DCDC1 gene and the PAX6 gene may be the new targets for promoting the treatments of cataracts using magnesium intervention.</p>
13 Authors
- Longman Li
- Wenjun Yang
- Lulu Huang
- Xiuming Feng
- Hong Cheng
- Xiaoting Ge
- Gaohui Zan
- Yanli Tan
- Lili Xiao
- Chaoqun Liu
- Xing Chen
- Zengnan Mo
- Xiaobo Yang
Enabling scientific discoveries that improve human health